ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,539,332, issued on Feb. 3, was assigned to A-BIOPHARMA (Montpellier, France).
"Anti-viral and hepatic-targeted drugs" was invented by Cyril B. Dousson (Canet, France) and David Dukhan (Montpellier, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are identified compound fragments, compounds and their pharmaceutically acceptable salts, isotopes or solvates, useful as antiviral drug and/or as a hepatic-targeted drug, such as for the treatment of HBV, HDV and/or HIV. Formula (I)."
The patent was filed on Oct. 19, 2020, under Application No. 17/769,131.
*For further information, including images, charts and tables, please visit: http:...